- Home
- AUST vs PMN Comparison
AUST vs PMN Comparison
Compare AUST & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUST
- PMN
- Stock Information
- Founded
- AUST 2020
- PMN 2004
- Country
- AUST Canada
- PMN Canada
- Employees
- AUST N/A
- PMN N/A
- Industry
- AUST
- PMN Pharmaceuticals and Biotechnology
- Sector
- AUST
- PMN Health Care
- Exchange
- AUST Nasdaq
- PMN Nasdaq
- Market Cap
- AUST 21.1M
- PMN 22.3M
- IPO Year
- AUST 2022
- PMN N/A
- Fundamental
- Price
- AUST $1.81
- PMN $0.42
- Analyst Decision
- AUST
- PMN Strong Buy
- Analyst Count
- AUST 0
- PMN 3
- Target Price
- AUST N/A
- PMN $4.33
- AVG Volume (30 Days)
- AUST 136.4K
- PMN 3.1M
- Earning Date
- AUST 11-05-2025
- PMN 11-13-2025
- Dividend Yield
- AUST N/A
- PMN N/A
- EPS Growth
- AUST N/A
- PMN N/A
- EPS
- AUST N/A
- PMN N/A
- Revenue
- AUST N/A
- PMN N/A
- Revenue This Year
- AUST N/A
- PMN N/A
- Revenue Next Year
- AUST N/A
- PMN N/A
- P/E Ratio
- AUST N/A
- PMN N/A
- Revenue Growth
- AUST N/A
- PMN N/A
- 52 Week Low
- AUST $0.95
- PMN $0.38
- 52 Week High
- AUST $3.19
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- AUST 65.59
- PMN 37.32
- Support Level
- AUST $1.72
- PMN $0.39
- Resistance Level
- AUST $1.95
- PMN $0.45
- Average True Range (ATR)
- AUST 0.13
- PMN 0.04
- MACD
- AUST 0.01
- PMN -0.01
- Stochastic Oscillator
- AUST 75.13
- PMN 16.71
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.